{"transactions":[{"id":3102437,"issuer":{"id":148291,"kind":"organization","name":"PROGENICS PHARMACEUTICALS INC","symbol":"PGNX"},"owners":[{"id":148294,"kind":"person","name":"Das Asha","position":1,"cik":"0001701647","reported_name":"Das Asha","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-23T16:49:43.000Z","date":"2020-06-19","kind":"disposition_to_issuer","acquired":false,"shares":82214,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On June 19, 2020, pursuant to the Amended and Restated Agreement and Plan of Merger, dated February 20, 2020 (the \"Merger Agreement\") among Lantheus Holdings, Inc. (\"Lantheus\"), Plato Merger Sub, Inc., a wholly-owned subsidiary of Lantheus (\"Merger Sub\"), and Progenics Pharmaceuticals, Inc. (\"Progenics\"), Merger Sub merged with and into Progenics (the \"Merger\"), with Progenics surviving as a wholly-owned subsidiary of Lantheus.  At the effective time of the Merger, this option was assumed by Lantheus and converted into an option to purchase Lantheus common stock based on an exchange ratio of 0.31 of a share of Lantheus common stock for each share of Progenics common stock subject to the option (with a corresponding adjustment being made to the exercise price of the option). Except for these adjustments, the current vesting and other terms of the option continue in effect."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is scheduled to vest in annual installments over the three-year period commencing March 2, 2020."}],"balance_after":0,"derivative":{"exercise_price":4.77,"expiration_date":"2030-03-02","underlying":"Common Stock","underlying_shares":82214},"source":{"system":"sec-edgar","filing":"0001437749-20-013681","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/835887/000143774920013681/rdgdoc.xml","form_type":"4"}},{"id":3102436,"issuer":{"id":148291,"kind":"organization","name":"PROGENICS PHARMACEUTICALS INC","symbol":"PGNX"},"owners":[{"id":148294,"kind":"person","name":"Das Asha","position":1,"cik":"0001701647","reported_name":"Das Asha","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-23T16:49:43.000Z","date":"2020-06-19","kind":"disposition_to_issuer","acquired":false,"shares":125000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On June 19, 2020, pursuant to the Amended and Restated Agreement and Plan of Merger, dated February 20, 2020 (the \"Merger Agreement\") among Lantheus Holdings, Inc. (\"Lantheus\"), Plato Merger Sub, Inc., a wholly-owned subsidiary of Lantheus (\"Merger Sub\"), and Progenics Pharmaceuticals, Inc. (\"Progenics\"), Merger Sub merged with and into Progenics (the \"Merger\"), with Progenics surviving as a wholly-owned subsidiary of Lantheus.  At the effective time of the Merger, this option was assumed by Lantheus and converted into an option to purchase Lantheus common stock based on an exchange ratio of 0.31 of a share of Lantheus common stock for each share of Progenics common stock subject to the option (with a corresponding adjustment being made to the exercise price of the option). Except for these adjustments, the current vesting and other terms of the option continue in effect."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option is scheduled to vest in annual installments over the five-year period commencing February 1, 2019."}],"balance_after":0,"derivative":{"exercise_price":4.56,"expiration_date":"2029-02-01","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001437749-20-013681","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/835887/000143774920013681/rdgdoc.xml","form_type":"4"}},{"id":3229461,"issuer":{"id":148291,"kind":"organization","name":"PROGENICS PHARMACEUTICALS INC","symbol":"PGNX"},"owners":[{"id":148294,"kind":"person","name":"Das Asha","position":1,"cik":"0001701647","reported_name":"Das Asha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2020-03-04T16:15:48.000Z","date":"2020-03-02","kind":"grant","acquired":true,"shares":82214,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"3yr 33% On Vest beginning on 02-Mar-2020"}],"balance_after":82214,"derivative":{"exercise_price":4.77,"expiration_date":"2030-03-02","underlying":"Common Stock","underlying_shares":82214},"source":{"system":"sec-edgar","filing":"0001562180-20-002136","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/835887/000156218020002136/primarydocument.xml","form_type":"4"}},{"id":3675751,"issuer":{"id":148291,"kind":"organization","name":"PROGENICS PHARMACEUTICALS INC","symbol":"PGNX"},"owners":[{"id":148294,"kind":"person","name":"Das Asha","position":1,"cik":"0001701647","reported_name":"Das Asha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2019-02-05T11:10:23.000Z","date":"2019-02-01","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"5yr 20% On Vest beginning on 01-Feb-2019"}],"balance_after":125000,"derivative":{"exercise_price":4.56,"expiration_date":"2029-02-01","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001562180-19-000755","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/835887/000156218019000755/primarydocument.xml","form_type":"4"}},{"id":4019746,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":148294,"kind":"person","name":"Das Asha","position":1,"cik":"0001701647","reported_name":"Das Asha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-03-02T22:13:25.000Z","date":"2018-03-01","kind":"grant","acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the shares vest one year after 3/01/2018; the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of 3/01/2018."}],"balance_after":70000,"derivative":{"exercise_price":11.19,"expiration_date":"2028-02-29","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001209191-18-015819","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000120919118015819/doc4.xml","form_type":"4"}},{"id":4131590,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":148294,"kind":"person","name":"Das Asha","position":1,"cik":"0001701647","reported_name":"Das Asha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-12-15T02:10:57.000Z","date":"2017-12-08","kind":"other","acquired":true,"shares":2500,"price":8.5,"value":21250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 is being filed voluntarily to report the acquisition of 2,500 shares by the Reporting Person on December 8, 2017 pursuant to the Issuer's Employee Stock Purchase Plan."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001209191-17-065793","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000120919117065793/doc4.xml","form_type":"4"}},{"id":4299707,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":148294,"kind":"person","name":"Das Asha","position":1,"cik":"0001701647","reported_name":"Das Asha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2017-06-01T01:12:37.000Z","date":"2017-05-26","kind":"grant","acquired":true,"shares":130000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the shares vest one year after 5/26/2017; the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of 5/26/2017."}],"balance_after":130000,"derivative":{"exercise_price":16.32,"expiration_date":"2027-05-25","underlying":"Common Stock","underlying_shares":130000},"source":{"system":"sec-edgar","filing":"0001209191-17-036623","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000120919117036623/doc4.xml","form_type":"4"}},{"id":4347419,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":148294,"kind":"person","name":"Das Asha","position":1,"cik":"0001701647","reported_name":"Das Asha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-04-21T21:44:06.000Z","date":"2017-04-19","kind":"purchase","acquired":true,"shares":2500,"price":10,"value":25000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were purchased at the Issuer's initial public offering."}],"balance_after":2500,"source":{"system":"sec-edgar","filing":"0001209191-17-027911","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000120919117027911/doc4.xml","form_type":"4"}},{"id":4353407,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":148294,"kind":"person","name":"Das Asha","position":1,"cik":"0001701647","reported_name":"Das Asha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2017-04-13T00:57:35.000Z","date":"2017-04-12","kind":"grant","acquired":true,"shares":7246,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the shares vest one year after 4/1/2017; the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of 4/1/2017."}],"balance_after":7246,"derivative":{"exercise_price":10,"expiration_date":"2027-04-11","underlying":"Common Stock","underlying_shares":7246},"source":{"system":"sec-edgar","filing":"0001209191-17-026749","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000120919117026749/doc4.xml","form_type":"4"}}]}